SecBot

8-K ·Filed Aug 5, 2026

$LIFECORE BIOMEDICAL, INC. \DE\ logo$

LFCR

LIFECORE BIOMEDICAL, INC. \DE\

NEUTRAL

Impact 5/10

Horizondays Processed1mo ago SEC0001005286-26-000032

8-K Item 2.02: Earnings release

Actionable Insight • Neutral

LLM returned non-JSON response. Review the filing manually.

DirectionNeutral

Confidencelow

Horizondays

Latest settled — T+20d

LFCR ▲ +6.76% at T+20d

NEUTRAL call ✓ call won +6.76% · α vs SPY +7.36% · entry $4.44 → $4.74

Next anchor: T+60d in 26d

Latest observation: T+39 +57.79% FF3 residual α

Entry anchored
Aug 5, 07:05 AM ET
via 1-min bar

T+1d

+9.01%

call +9.01% · α +9.17%

$4.84

settled 8w ago

T+5d

+7.43%

call +7.43% · α +7.08%

$4.77

settled 7w ago

T+20d

+6.76%

call +6.76% · α +7.36%

$4.74

settled 4w ago

T+60d

—

call — · α —

—

in 26d

Price Chart

Loading chart...

Executive Summary

{ "summary": "Lifecore Biomedical reported Q2 2026 revenue of $34.2M (down 6.2% YoY), a GAAP net loss of $6.2M ($0.19 per share vs consensus -$0.17), and Adjusted EBITDA of $8.6M (slightly below $9.1M prior year). Despite the revenue decline and wider net loss, the company reaffirmed its full-year 2026 guidance ($120-125M revenue, $20.5-25M Adjusted EBITDA) and highlighted strong pipeline growth with 13 new programs added over the past 12 months, including 8 late-stage. The combination of stab

Financial Impact

Unknown

Risk Factors

Analysis may be incomplete

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

73% bullish (11 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001005286-26-000032
Exhibit: ex992_lfcrpresentation.htm	0001005286-26-000032
Document: lfcr-20260805.htm	0001005286-26-000032
Document: 0001005286-26-000032-index-headers.html	0001005286-26-000032
Document: 0001005286-26-000032-index.html	0001005286-26-000032
Document: 0001005286-26-000032.txt	0001005286-26-000032
8-K Data (Synthetic)	0001005286-26-000032

9 reports for LFCR

T+1T+5T+20T+60

100% Hit rate 4 of 4 directional calls best @ T+60▲ +45.27%Mar 26, 2026

Filters

Reports for LFCR — sortable, filterable
	Type				Now
Aug 5, 2026 8w ago	8-K NEUTRAL ★ 5/10	$4.44 $4.74	▲ +6.76%	▲ +7.36%	$6.53 (+47.07%)
Jul 2, 2026 13w ago	8-K BEARISH ★ 7/10	$5.09 $4.36	▲ +14.34%	▲ +13.93%	$6.53 (−28.29%)
Jun 15, 2026 15w ago	Press Release BULLISH ★ 6/10	$5.49 $4.63	▼ −15.66%	▼ −14.91%	$6.53 (+18.94%)
Jun 5, 2026 17w ago	8-K NEUTRAL ★ 3/10	$5.57 $5.05	▼ −9.34%	▼ −10.97%	$6.53 (+17.24%)
Jun 2, 2026 17w ago	Press Release NEUTRAL ★ 4/10	$5.45 $5.27	▼ −3.30%	▼ −1.74%	$6.53 (+19.82%)
May 6, 2026 21w ago	8-K BEARISH ★ 7/10	$4.96 $5.67	▼ −14.31%	▼ −11.53%	$6.53 (−31.65%)
Mar 26, 2026 27w ago	Press Release BULLISH ★ 7/10	$3.87 $5.02	▲ +29.72%	▲ +19.05%	$6.53 (+68.73%)
Mar 16, 2026 28w ago	Press Release MIXED ★ 6/10	$4.37 $5.20	▲ +18.99%	▲ +15.21%	$6.53 (+49.43%)
Mar 4, 2026 30w ago	Press Release NEUTRAL ★ 4/10	$7.02 $3.84	▼ −45.30%	▼ −41.51%	$6.53 (−6.98%)

US Market Status

Market Closed — Opens Mon (37h 29m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access